Skip to main content

Advertisement

SpringerLink
Log in

Overview of vasculitis and vasculopathy in rheumatoid arthritis—something to think about

  • Review Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The vasculature plays a crucial role in inflammation and atherosclerosis associated with the pathogenesis of rheumatoid arthritis. Vasculitis in rheumatoid arthritis is associated with longstanding disease, has an important impact on a patient’s quality of life and influences patient life expectancy. Seropositivity, specific human leukocyte antigen variations, antibodies to cyclic citrullinated peptides, and cigarette smoking are among the genetic and environmental predictors of rheumatoid vasculitis. Atherosclerosis is an early and common finding in rheumatoid arthritis and it correlates with disease duration, activity, and severity. Apart from conventional risk factors such as cigarette smoking, physical inactivity, obesity, arterial hypertension, dyslipidemia and diabetes mellitus, rheumatoid arthritis-related risk factors including disease duration, severity and activity, rheumatoid factor and antibodies to cyclic citrullinated peptides status, functional impairment, C-reactive protein, radiographic changes, presence of the shared epitope, and treatment modalities are all implicated in the development of accelerated atherosclerosis. Atherosclerosis is also considered an inflammatory disease; thus, it may share common pathogenic mechanisms with rheumatic diseases such as rheumatoid arthritis. Advances in treatment of rheumatoid arthritis with disease-modifying biologic and nonbiologic agents will probably continue to reduce the incidence of vasculitis. Since the goal of treatment for rheumatoid arthritis is to decrease inflammatory burden, successful treatment may theoretically reduce the risk of accelerated atherosclerosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Szekanecz Z, Koch AE (2008) Vascular involvement in rheumatic diseases: ‘vascular rheumatology’. Arthritis Res Ther 10(5):224

    Article  PubMed  Google Scholar 

  2. Kitas GD, Gabriel SE (2011) Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives. Ann Rheum Dis 70(1):8–14

    Article  PubMed  Google Scholar 

  3. Puechal X, Said G, Hilliquin P, Coste J, Job-Deslandre C, Lacroix C et al (1995) Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis. A clinicopathologic and prognostic study of thirty-two patients. Arthritis Rheum 38(11):1618–29

    Article  PubMed  CAS  Google Scholar 

  4. Scott DG, Bacon PA, Tribe CR (1981) Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore) 60(4):288–97

    CAS  Google Scholar 

  5. Pagnoux C, Mahr A, Cohen P, Guillevin L (2005) Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg–Strauss syndrome, or rheumatoid arthritis-associated vasculitis. Medicine (Baltimore) 84(2):115–28

    Article  Google Scholar 

  6. Scott DGI, Bacon PA, Allen C, Elson CJ, Wallington T (1981) Igg rheumatoid-factor, complement and immune-complexes in rheumatoid synovitis and vasculitis—comparative and serial studies during cyto-toxic therapy. Clin Exp Immunol 43(1):54–63

    PubMed  CAS  Google Scholar 

  7. Turesson C, Jacobsson LT, Sturfelt G, Matteson EL, Mathsson L, Ronnelid J (2007) Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis. Ann Rheum Dis 66(1):59–64

    Article  PubMed  CAS  Google Scholar 

  8. Watts RA, Carruthers DM, Symmons DP, Scott DG (1994) The incidence of rheumatoid vasculitis in the Norwich Health Authority. Br J Rheumatol 33(9):832–3

    Article  PubMed  CAS  Google Scholar 

  9. Voskuyl AE, van Duinen SG, Zwinderman AH, Breedveld FC, Hazes JM (1998) The diagnostic value of perivascular infiltrates in muscle biopsy specimens for the assessment of rheumatoid vasculitis. Ann Rheum Dis 57(2):114–7

    Article  PubMed  CAS  Google Scholar 

  10. Turesson C, McClelland RL, Christianson T, Matteson E (2008) Clustering of extraarticular manifestations in patients with rheumatoid arthritis. J Rheumatol 35(1):179–80

    PubMed  Google Scholar 

  11. Struthers GR, Scott DL, Delamere JP, Sheppeard H, Kitt M (1981) Smoking and rheumatoid vasculitis. Rheumatol Int 1(3):145–6

    Article  PubMed  CAS  Google Scholar 

  12. Turesson C, Schaid DJ, Weyand CM, Jacobsson LT, Goronzy JJ, Petersson IF et al (2006) Association of HLA-C3 and smoking with vasculitis in patients with rheumatoid arthritis. Arthritis Rheum 54(9):2776–83

    Article  PubMed  Google Scholar 

  13. Turesson C, Schaid DJ, Weyand CM, Jacobsson LT, Goronzy JJ, Petersson IF et al (2005) The impact of HLA-DRB1 genes on extra-articular disease manifestations in rheumatoid arthritis. Arthritis Res Ther 7(6):R1386–93

    Article  PubMed  CAS  Google Scholar 

  14. Gorman JD, David-Vaudey E, Pai M, Lum RF, Criswell LA (2004) Particular HLA-DRB1 shared epitope genotypes are strongly associated with rheumatoid vasculitis. Arthritis Rheum 50(11):3476–84

    Article  PubMed  CAS  Google Scholar 

  15. Turesson C, O’Fallon WM, Crowson CS, Gabriel SE, Matteson EL (2002) Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 29(1):62–7

    PubMed  Google Scholar 

  16. Turesson C, McClelland RL, Christianson TJ, Matteson EL (2007) Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis 66(1):70–5

    Article  PubMed  CAS  Google Scholar 

  17. Doran MF, Crowson CS, Pond GR, O’Fallon WM, Gabriel SE (2002) Predictors of infection in rheumatoid arthritis. Arthritis Rheum 46(9):2294–300

    Article  PubMed  Google Scholar 

  18. Iyngkaran P, Limaye V, Hill C, Henderson D, Pile KD, Rischmueller M (2003) Rheumatoid vasculitis following influenza vaccination. Rheumatology (Oxford) 42(7):907–9

    Article  CAS  Google Scholar 

  19. Watts RA, Carruthers DM, Scott DG (1995) Isolated nail fold vasculitis in rheumatoid arthritis. Ann Rheum Dis 54(11):927–9

    Article  PubMed  CAS  Google Scholar 

  20. Jorizzo JL, Daniels JC (1983) Dermatologic conditions reported in patients with rheumatoid arthritis. J Am Acad Dermatol 8(4):439–57

    Article  PubMed  CAS  Google Scholar 

  21. Geirsson AJ, Sturfelt G, Truedsson L (1987) Clinical and serological features of severe vasculitis in rheumatoid arthritis: prognostic implications. Ann Rheum Dis 46(10):727–33

    Article  PubMed  CAS  Google Scholar 

  22. Achkar AA, Stanson AW, Johnson M, Srivatsa SS, Dale LC, Weyand CM (1995) Rheumatoid vasculitis manifesting as intraabdominal hemorrhage. Mayo Clin Proc 70(6):565–9

    Article  PubMed  CAS  Google Scholar 

  23. Said G, Lacroix C (2005) Primary and secondary vasculitic neuropathy. J Neurol 252(6):633–41

    Article  PubMed  Google Scholar 

  24. Boers M, Croonen AM, Dijkmans BAC, Breedveld FC, Eulderink F, Cats A et al (1987) Renal findings in rheumatoid-arthritis—clinical aspects of 132 necropsies. Ann Rheum Dis 46(9):658–63

    Article  PubMed  CAS  Google Scholar 

  25. Radic M, Martinovic Kaliterna D, Radic J (2012) Drug-induced vasculitis: a clinical and pathological review. Neth J Med 70(1):12–7

    PubMed  CAS  Google Scholar 

  26. Unger L, Kayser M, Nusslein HG (2003) Successful treatment of severe rheumatoid vasculitis by infliximab. Ann Rheum Dis 62(6):587–8

    Article  PubMed  CAS  Google Scholar 

  27. Puechal X, Miceli-Richard C, Mejjad O, Lafforgue P, Marcelli C, Solau-Gervais E et al (2008) Anti-tumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritis. Ann Rheum Dis 67(6):880–4

    Article  PubMed  CAS  Google Scholar 

  28. Jones RB, Tervaert JWC, Hauser T, Luqmani R, Morgan MD, Peh CA et al (2010) Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 363(3):211–20

    Article  PubMed  CAS  Google Scholar 

  29. Assmann G, Pfreundschuh M, Voswinkel J (2010) Rituximab in patients with rheumatoid arthritis and vasculitis-associated cutaneous ulcers. Clin Exp Rheumatol 28(1):S81–S3

    Google Scholar 

  30. Puechal X, Gottenberg JE, Berthelot JM, Gossec L, Meyer O, Morel J et al (2012) Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: Results from the autoimmunity and rituximab registry. Arthritis Care Res (Hoboken) 64(3):331–9

    Article  CAS  Google Scholar 

  31. Sumida K, Ubara Y, Takemoto F, Takaichi K (2011) Successful treatment with humanised anti-interleukin 6 receptor antibody for multidrug-refractory and anti-tumour necrosis factor-resistant systemic rheumatoid vasculitis. Clin Exp Rheumatol 29(1):S133-S

    Google Scholar 

  32. Fujii W, Kohno M, Ishino H, Nakabayashi A, Fujioka K, Kida T et al (2012) The rapid efficacy of abatacept in a patient with rheumatoid vasculitis. Mod Rheumatol 22(4):630–4

    Article  PubMed  Google Scholar 

  33. Libby P (2008) Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am J Med 121(10):21–31

    Article  Google Scholar 

  34. Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J (2005) Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Sem Arth Rheum 35(1):8–17

    Article  Google Scholar 

  35. Sokka T, Abelson B, Pincus T (2008) Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol 26(5):S35–S61

    PubMed  CAS  Google Scholar 

  36. Van Doornum S, McColl G, Wicks IP (2002) Accelerated atherosclerosis—an extraarticular feature of rheumatoid arthritis? Arthritis Rheum 46(4):862–73

    Article  PubMed  Google Scholar 

  37. Pasceri V, Yeh ETH (1999) A tale of two diseases—atherosclerosis and rheumatoid arthritis. Circulation 100(21):2124–6

    Article  PubMed  CAS  Google Scholar 

  38. Sherer Y, Shoenfeld Y (2006) Mechanisms of disease: atherosclerosis in autoimmune diseases. Nat Clin Pract Rheumatol 2(2):99–106

    Article  PubMed  CAS  Google Scholar 

  39. del Rincon I, Williams K, Stern MP, Freeman GL, Escalante A (2001) High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 44(12):2737–45

    Article  PubMed  Google Scholar 

  40. Kerekes G, Szekanecz Z, Der H, Sandor Z, Lakos G, Muszbek L et al (2008) Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using Imaging techniques and laboratory markers of inflammation and autoimmunity. J Rheumatol 35(3):398–406

    PubMed  CAS  Google Scholar 

  41. Kaplan MJ (2009) Management of cardiovascular disease risk in chronic inflammatory disorders. Nat Rev Rheumatol 5(4):208–17

    Article  PubMed  Google Scholar 

  42. Giles JT, Post W, Blumenthal RS, Bathon JM (2006) Therapy insight: managing cardiovascular risk in patients with rheumatoid arthritis. Nat Clin Pract Rheumatol 2(6):320–9

    Article  PubMed  CAS  Google Scholar 

  43. Roubenoff R, Dellaripa P, Nadeau MR, Abad LW, Muldoon BA, Selhub J et al (1997) Abnormal homocysteine metabolism in rheumatoid arthritis. Arthritis Rheum 40(4):718–22

    Article  PubMed  CAS  Google Scholar 

  44. Hannawi S, Marwick TH, Thomas R (2009) Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis. Arthritis Res Ther. doi:10.1186/ar2668

    PubMed  Google Scholar 

  45. Hansson GK (2001) Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 21(12):1876–90

    Article  PubMed  CAS  Google Scholar 

  46. Bacons PA, Kitas GD (1994) The significance of vascular inflammation in rheumatoid arthritis. Ann Rheum Dis 53(10):621–3

    Article  PubMed  CAS  Google Scholar 

  47. Del Porto F, Lagana B, Lai S, Nofroni I, Tinti F, Vitale M et al (2007) Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis. Rheumatology 46(7):1111–5

    Article  PubMed  Google Scholar 

  48. Maki-Petaja KM, Elkhawad M, Cheriyan J, Joshi FR, Ostor AJ, Hall FC et al (2012) Anti-tumor necrosis factor-alpha therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis. Circulation 126(21):2473–80

    Article  PubMed  Google Scholar 

  49. Nurmohamed MT, Kitas G (2011) Cardiovascular risk in rheumatoid arthritis and diabetes: how does it compare and when does it start? Ann Rheum Dis 70(6):881–3

    Article  PubMed  Google Scholar 

  50. John H, Toms TE, Kitas GD (2011) Rheumatoid arthritis: is it a coronary heart disease equivalent? Curr Opin Cardiol 26(4):327–33

    Article  PubMed  Google Scholar 

Download references

Disclosures

None.

Author information

Authors and Affiliations

  1. Division of Rheumatology and Clinical Immunology, University of Split School of Medicine, University Hospital Centre Split, Šižgorićeva 20/II, 21 000, Split, Croatia

    Mislav Radic & Dusanka Martinovic Kaliterna

  2. Division of Nephrology, University of Split School of Medicine, University Hospital Centre Split, Split, Croatia

    Josipa Radic

Authors
  1. Mislav Radic
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dusanka Martinovic Kaliterna
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Josipa Radic
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mislav Radic.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Radic, M., Kaliterna, D.M. & Radic, J. Overview of vasculitis and vasculopathy in rheumatoid arthritis—something to think about. Clin Rheumatol 32, 937–942 (2013). https://doi.org/10.1007/s10067-013-2273-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-013-2273-8

Keywords

Search

Navigation